Brain, Vol. 122, No. 8, 1403-1420,
August 1999
© 1999 Oxford University Press
Invited review |
Making sense of the limb-girdle muscular dystrophies
Department of Biochemistry and Genetics, University of Newcastle-upon-Tyne, UK
Correspondence to:
Katharine M. D. Bushby, Department of Biochemistry and Genetics, University of Newcastle-upon-Tyne, 19/20 Claremont Place, Newcastle-upon-Tyne NE2 4AA, UK E-mail: kate.bushby{at}ncl.ac.uk
The clinical heterogeneity which has long been recognized in the limb-girdle muscular dystrophies (LGMD) has been shown to relate to the involvement of a large number of different genes. At least eight forms of autosomal recessive LGMD and three forms of autosomal dominant disease are now recognized and can be defined by the primary gene or protein involved, or by a genetic localization. These advances have combined the approaches of positional cloning and candidate gene analysis to great effect, with the pivotal role of the dystrophin-associated complex confirmed through the involvement of at least four dystrophin-associated proteins in different subtypes of autosomal recessive LGMD (the sarcoglycanopathies). Two novel mechanisms may have to be postulated to explain the involvement of the calpain 3 and dysferlin genes in other forms of LGMD. Using the diagnostic tools which have become available as a result of this increased understanding, the clinical features of the various subtypes are also becoming clearer, with useful diagnostic and prognostic information at last available to the practising clinician.
limb-girdle; LGMD; sarcoglycan; calpain; dysferlin
DGC = dystrophin–glycoprotein complex; FSHD = facioscapulohumeral muscular dystrophy; LGMD = limb-girdle muscular dystrophies
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Kobuke, F. Piccolo, K. W. Garringer, S. A. Moore, E. Sweezer, B. Yang, and K. P. Campbell A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice Hum. Mol. Genet., May 1, 2008; 17(9): 1201 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Illa, N. De Luna, R. Dominguez-Perles, R. Rojas-Garcia, C. Paradas, J. Palmer, C. Marquez, P. Gallano, and E. Gallardo Symptomatic dysferlin gene mutation carriers: Characterization of two cases Neurology, April 17, 2007; 68(16): 1284 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jarry, M. F. Rioux, V. Bolduc, Y. Robitaille, V. Khoury, I. Thiffault, M. Tetreault, L. Loisel, J. P. Bouchard, and B. Brais A novel autosomal recessive limb-girdle muscular dystrophy with quadriceps atrophy maps to 11p13-p12 Brain, February 1, 2007; 130(2): 368 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. de Luna, E. Gallardo, M. Soriano, R. Dominguez-Perles, C. de la Torre, R. Rojas-Garcia, J. M. Garcia-Verdugo, and I. Illa Absence of Dysferlin Alters Myogenin Expression and Delays Human Muscle Differentiation "in Vitro" J. Biol. Chem., June 23, 2006; 281(25): 17092 - 17098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Tsao and J.R. Mendel Coexisting Muscular Dystrophies and Epilepsy in Children J Child Neurol, February 1, 2006; 21(2): 148 - 150. [Abstract] [PDF]
|
|
|
|
 |
|
 J. J. Vilchez, P. Gallano, E. Gallardo, A. Lasa, R. Rojas-Garcia, A. Freixas, N. De Luna, F. Calafell, T. Sevilla, F. Mayordomo, et al. Identification of a Novel Founder Mutation in the DYSF Gene Causing Clinical Variability in the Spanish Population Arch Neurol, August 1, 2005; 62(8): 1256 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Woodman, F. Sotgia, F. Galbiati, C. Minetti, and M. P. Lisanti Caveolinopathies: Mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases Neurology, February 24, 2004; 62(4): 538 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Palenzuela, A.L. Andreu, J. Gamez, M.R. Vila, T. Kunimatsu, A. Meseguer, C. Cervera, I. Fernandez Cadenas, P.F.M. van der Ven, T.G. Nygaard, et al. A novel autosomal dominant limb-girdle muscular dystrophy (LGMD 1F) maps to 7q32.1-32.2 Neurology, August 12, 2003; 61(3): 404 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Boito, M Fanin, G Siciliano, C Angelini, and E Pegoraro Novel sarcoglycan gene mutations in a large cohort of Italian patients J. Med. Genet., May 1, 2003; 40(5): e67 - 67. [Full Text] [PDF]
|
|
|
|
|
|
M. Poppe, L. Cree, J. Bourke, M. Eagle, L.V.B. Anderson, D. Birchall, M. Brockington, M. Buddles, M. Busby, F. Muntoni, et al. The phenotype of limb-girdle muscular dystrophy type 2I Neurology, April 22, 2003; 60(8): 1246 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E S Moreira, M Vainzof, O T Suzuki, R C M Pavanello, M Zatz, and M R Passos-Bueno Genotype-phenotype correlations in 35 Brazilian families with sarcoglycanopathies including the description of three novel mutations J. Med. Genet., February 1, 2003; 40(2): e12 - 12. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ehmsen, E. Poon, and K. Davies The dystrophin-associated protein complex J. Cell Sci., July 15, 2002; 115(14): 2801 - 2803. [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Bergman, K. D. Inzana, W. E. Monroe, L. G. Shell, L. A. Liu, E. Engvall, and G. D. Shelton Dystrophin-Deficient Muscular Dystrophy in a Labrador Retriever J. Am. Anim. Hosp. Assoc., May 1, 2002; 38(3): 255 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.P. Dickinson CYSTEINE PEPTIDASES OF MAMMALS: THEIR BIOLOGICAL ROLES AND POTENTIAL EFFECTS IN THE ORAL CAVITY AND OTHER TISSUES IN HEALTH AND DISEASE Critical Reviews in Oral Biology & Medicine, May 1, 2002; 13(3): 238 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aoki, J. Liu, I. Richard, R. Bashir, S. Britton, S. M. Keers, J. Oeltjen, H. E. V. Brown, S. Marchand, N. Bourg, et al. Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy Neurology, July 24, 2001; 57(2): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I N Sheriffs, D Rampling, and V V Smith Paraffin wax embedded muscle is suitable for the diagnosis of muscular dystrophy J. Clin. Pathol., July 1, 2001; 54(7): 517 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Talim, A. Ognibene, E. Mattioli, I. Richard, L.V.B. Anderson, and L. Merlini Normal calpain expression in genetically confirmed limb-girdle muscular dystrophy type 2A Neurology, March 13, 2001; 56(5): 692 - 693. [Full Text] [PDF]
|
|
|
|
|
|
J. Gamez, C. Navarro, A.L. Andreu, J.M. Fernandez, L. Palenzuela, S. Tejeira, R. Fernandez-Hojas, S. Schwartz, C. Karadimas, S. DiMauro, et al. Autosomal dominant limb-girdle muscular dystrophy: A large kindred with evidence for anticipation Neurology, February 27, 2001; 56(4): 450 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Argov, M. Sadeh, K. Mazor, D. Soffer, E. Kahana, I. Eisenberg, S. Mitrani-Rosenbaum, I. Richard, J. Beckmann, S. Keers, et al. Muscular dystrophy due to dysferlin deficiency in Libyan Jews: Clinical and genetic features Brain, June 1, 2000; 123(6): 1229 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Torreggiani, I. D. Lyburn, A. C. Harris, and V. A. Rowley Duchenne-Landouzy Dystrophy: CT Explanation of Low Serum CreatinineLevel Am. J. Roentgenol., May 1, 2000; 174(5): 1467 - 1468. [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Lebakken, D. P. Venzke, R. F. Hrstka, C. M. Consolino, J. A. Faulkner, R. A. Williamson, and K. P. Campbell Sarcospan-Deficient Mice Maintain Normal Muscle Function Mol. Cell. Biol., March 1, 2000; 20(5): 1669 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Progress in Understanding the Limb-Girdle Muscular Dystrophies Journal Watch Neurology, December 1, 1999; 1999(1201): 10 - 10. [Full Text]
|
|
|
|
|
|
K. M. D. Bushby The limb-girdle muscular dystrophies--multiple genes,multiple mechanisms Hum. Mol. Genet., September 1, 1999; 8(10): 1875 - 1882. [Abstract] [Full Text] [PDF]
|
|